Shots:
The company launched the new NfL blood test that allows doctors to identify and verify signs of neurodegenerative disease along with diagnosing and treat patients more quickly & effectively
The test measures key biomarkers associated with neuronal damage; assists in the diagnosis of diseases incl. MS, AD Parkinson’s, or brain injury. It is anticipated that having a wide range of diagnostic tools available to doctors will have a positive impact on the ability to diagnose & treat numerous conditions more successfully
The test’s launch and availability showed Labcorp’s dedication to neurology and to enhance the health and lives of people suffering from neurodegenerative and related disorders
Ref: Bussinesswire | Image: Labcorp
